Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IP Group PLC Director's Dealing 2022

Oct 31, 2022

4852_dirs_2022-10-31_0664e167-58cd-477b-bc2f-7ca69ed980df.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

RNS Number : 7936E

IP Group PLC

31 October 2022

FOR RELEASE ON # 31 October 2022

IP Group plc - PDMR share purchase

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which develops world-changing science and technology businesses across life sciences, technology and cleantech,has been notified that on 28 October 2022, Christopher Glasson, Finance Director and a PDMR, purchased a total of 74,615 ordinary shares of two pence each ("Shares") as outlined in the below table.

Name Number of Shares acquired Price per share (£) Resultant beneficial interest (in Shares)
Christopher Glasson 74,615 £0.59 137,749

The notification below, made in accordance with the requirements of article 19 of the UK Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Christopher Glasson

2

Reason for the notification

a)

Position/status

Finance Director (PDMR)

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

LEI

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

ISIN: GB00B128J450

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
59 pence per share 74,615

d)

Aggregated information

-     Aggregated volume

-     Price

Not applicable - single transaction

e)

Date of the transaction

28 October 2022

f)

Place of the transaction

London Stock Exchange, Main Market

For more information, please contact:

IP Group plc www.ipgroupplc.com
David Baynes, Chief Financial and Operating Officer

Liz Vaughan-Adams, Communications
+44 (0) 20 7444 0050

+44 (0) 20 7444 0062/+44 (0) 7967 312125

Notes for editors

About IP Group

IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech (through Kiko Ventures). The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

For more information, please visit our website at www.ipgroupplc.com.

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHWPGCWUUPPGQG